Tag Archives: PTAB

Director Iancu’s IPO Address and Judge Rich

Posted on September 27, 2018 by Warren Woessner

Although Director Iancu’s address primarily aims at the difficulty of determining when a claim is directed to an abstract idea, his precursor guiding light is clearly the late Judge Giles Rich. Notably, Iancu quotes from Judge Rich. These quotes are … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , | Leave a comment

“Big Data” Claims Meet Mayo/Alice Rule

Posted on September 24, 2018 by Warren Woessner

I am going to try to discuss two recent decisions by the PTAB, Ex parte Fiesner, Appeal 2018-00530 (9-10-18) and Ex parte Lehrer, Appeal 2016-007941 (8-29-2018). Both have claims that employ computers to process large amounts of input data to, … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , | Leave a comment

BIO IP & Diagnostics Conference – Is the Titanic Turning Around?

Posted on September 21, 2018 by Warren Woessner

On September 28th, I will be moderating a panel on patenting diagnostic tests – and related subject matter – such as methods of medical treatment, at BIO’s annual IP & Diagnostics Symposium in Alexandria, VA. At the beginning of 2018, … Continue reading →

Posted in BIO, Patent Eligible Subject Matter | Tagged , , , , , | Leave a comment

Ex parte Parenteau – PTAB Skips Step One of the Mayo/Alice Test?

Posted on September 14, 2018 by Warren Woessner

In ex parte Ho, the subject of my last post, the PTAB reversed the Examiner’s rejection of claims to a population of bone marrow cells obtained by two-stage culturing that expressed or failed to express certain markers. The PTAB wrote … Continue reading →

Posted in Patent Eligible Subject Matter, Section 103 | Tagged , , , , , , , , | Leave a comment